seed
Stage
1
Investors
About
Delineate develops AI-powered agents to optimize the design and planning of clinical trials, aiming to reduce time and costs in drug development.
Explore Delineate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.